These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 31221474)

  • 1. The utility of a statewide prescription drug-monitoring database vs the Current Opioid Misuse Measure for identifying drug-aberrant behaviors in emergency department patients already on opioids.
    Wilson MP; Cucciare MA; Porter A; Chalmers CE; Mullinax S; Mancino M; Oliveto AH
    Am J Emerg Med; 2020 Mar; 38(3):503-507. PubMed ID: 31221474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening Tools Validated in the Outpatient Pain Management Setting Poorly Predict Opioid Misuse in the Emergency Department: A Pilot Study.
    Chalmers CE; Mullinax S; Brennan J; Vilke GM; Oliveto AH; Wilson MP
    J Emerg Med; 2019 Jun; 56(6):601-610. PubMed ID: 31043338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM).
    Meltzer EC; Rybin D; Saitz R; Samet JH; Schwartz SL; Butler SF; Liebschutz JM
    Pain; 2011 Feb; 152(2):397-402. PubMed ID: 21177035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of an opioid abuse screening tool and prescription drug monitoring data in the emergency department.
    Weiner SG; Horton LC; Green TC; Butler SF
    Drug Alcohol Depend; 2016 Feb; 159():152-7. PubMed ID: 26743334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).
    Lin DH; Lucas E; Murimi IB; Jackson K; Baier M; Frattaroli S; Gielen AC; Moyo P; Simoni-Wastila L; Alexander GC
    Addiction; 2017 Feb; 112(2):311-319. PubMed ID: 27658522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstate data sharing of prescription drug monitoring programs and associated opioid prescriptions among patients with non-cancer chronic pain.
    Lin HC; Wang Z; Simoni-Wastila L; Boyd C; Buu A
    Prev Med; 2019 Jan; 118():59-65. PubMed ID: 30316875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting aberrant opioid behavior in the emergency department: a prospective study using the screener and Opioid Assessment for Patients with Pain-Revised (SOAPP
    Varney SM; Perez CA; Araña AA; Carey KR; Ganem VJ; Zarzabal LA; Ramos RG; Bebarta VS
    Intern Emerg Med; 2018 Dec; 13(8):1239-1247. PubMed ID: 29502329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect Of A "No Superuser Opioid Prescription" Policy On ED Visits And Statewide Opioid Prescription.
    Kahler ZP; Musey PI; Schaffer JT; Johnson AN; Strachan CC; Shufflebarger CM
    West J Emerg Med; 2017 Aug; 18(5):894-902. PubMed ID: 28874942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Past-year Prescription Drug Monitoring Program Opioid Prescriptions and Self-reported Opioid Use in an Emergency Department Population With Opioid Use Disorder.
    Hawk K; D'Onofrio G; Fiellin DA; Chawarski MC; O'Connor PG; Owens PH; Pantalon MV; Bernstein SL
    Acad Emerg Med; 2018 May; 25(5):508-516. PubMed ID: 29165853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
    Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
    Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the Use of a Mandatory Prescription Drug Monitoring Program With Prescribing Practices for Patients Undergoing Elective Surgery.
    Stucke RS; Kelly JL; Mathis KA; Hill MV; Barth RJ
    JAMA Surg; 2018 Dec; 153(12):1105-1110. PubMed ID: 30140927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provider Prescription Drug Monitoring Program Utilization and Self-Auditing-A Pilot Study.
    Brown WC; Whitted K
    J Dr Nurs Pract; 2020 Jul; 13(2):142-147. PubMed ID: 32817503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in prescription drug monitoring program use by prescriber specialty.
    Sun BC; Lupulescu-Mann N; Charlesworth CJ; Kim H; Hartung DM; Deyo RA; John McConnell K
    J Subst Abuse Treat; 2018 Nov; 94():35-40. PubMed ID: 30243415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Prescription Drug Monitoring Programs and Prescribing Guidelines on Emergency Department Opioid Prescribing: A Multi-Center Survey.
    Pomerleau AC; Nelson LS; Hoppe JA; Salzman M; Weiss PS; Perrone J
    Pain Med; 2017 May; 18(5):889-897. PubMed ID: 26995800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline.
    Chou R; Fanciullo GJ; Fine PG; Miaskowski C; Passik SD; Portenoy RK
    J Pain; 2009 Feb; 10(2):131-46. PubMed ID: 19187890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating Emergency Department Opioid Prescribing Behaviors After Education About Mandated Use of the Pennsylvania Prescription Drug Monitoring Program.
    Martello J; Cassidy B; Mitchell A
    J Addict Nurs; 2018; 29(3):196-202. PubMed ID: 30180006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doctor hopping and doctor shopping for prescription opioids associated with increased odds of high-risk use.
    Young SG; Hayes CJ; Aram J; Tait MA
    Pharmacoepidemiol Drug Saf; 2019 Aug; 28(8):1117-1124. PubMed ID: 31168860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a legislative mandate on opioid prescribing for back pain in the emergency department.
    Khobrani M; Perona S; Patanwala AE
    Am J Emerg Med; 2019 Nov; 37(11):2035-2038. PubMed ID: 30824275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians.
    Irvine JM; Hallvik SE; Hildebran C; Marino M; Beran T; Deyo RA
    J Pain; 2014 Jul; 15(7):747-55. PubMed ID: 24787089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.